Spain crowns biomedical R&D drive with stem cell vision:
This article was originally published in Clinica
Executive Summary
"Embryonic stem cell research is ... the most promising route to finding therapeutic solutions for diseases that do not now have a cure." So said Spanish health minister and professor of molecular biology and regenerative medicine Bernat Soria last week. He was speaking at the conference "Biomedical research in Spain: a policy full of prospects", hosted by the national academy of medicine (RANM) to mark the end of its 2007 academic session. The event also served to celebrate Professor Soria's role in overseeing the significant development of biomedical R&D this year. His ministerial appointment followed the approval in June of the biomedical research law, paving the way for stem cell research.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.